“Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study” (2014) Reumatismo, 66(3), pp. 224–232. doi:10.4081/reumatismo.2014.748.